Connection
Maryam Shakiba to Glucose
This is a "connection" page, showing publications Maryam Shakiba has written about Glucose.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
0.238 |
|
|
|
-
Shakiba M, Nazemipour M, Mansournia N, Mansournia MA. Protective effect of intensive glucose lowering therapy on all-cause mortality, adjusted for treatment switching using G-estimation method, the ACCORD trial. Sci Rep. 2023 04 10; 13(1):5833.
Score: 0.151
-
Hashemi Nazari SS, Shakiba M, Khalili D, Hadaegh F, Tohidi M, Azizi F. High-density lipoprotein cholesterol, a protective or a risk factor for developing coronary heart disease? Tehran Lipid and Glucose Study. J Clin Lipidol. 2015 Jul-Aug; 9(4):553-8.
Score: 0.087